In other countries
The same active substances on other registers, the same brand first.
- EXELON 1,5 mg CAPSULAS DURASSpain · 1,5 mg · cápsula dura · Novartis Europharm LimitedSame form
- EXELON 1,5 mg CAPSULAS DURASSpain · 1,5 mg · cápsula dura · Novartis Europharm LimitedSame form
- EXELON 1,5 mg CAPSULAS DURASSpain · 1,5 mg · cápsula dura · Novartis Europharm LimitedSame form
- ExelonItaly · Capsula rigida · BB Farma S.R.L.Same form
- NimvastidItaly · Capsula rigida · Krka D.D. Novo MestoSame form
- PrometaxItaly · Capsula rigida · Almirall S.A.Same form
- Exelon 1,5 mg, harde capsulesNetherlands · Capsule, hard · Novartis Europharm LimitedSame form
- Exelon 3,0 mg, harde capsulesNetherlands · Capsule, hard · Novartis Europharm LimitedSame form
- Exelon 4,5 mg, harde capsulesNetherlands · Capsule, hard · Novartis Europharm LimitedSame form
- NIMVASTID 1.5mgRomania · 1.5mg · caps. · Krka ,D.D., Novo MestoSame form
- NIMVASTID 3mgRomania · 3mg · caps. · Krka ,D.D., Novo MestoSame form
- RIDAXIN 1,5 mgRomania · 1,5mg · caps. · Neola Pharma SRLSame form
- Exelon®Serbia · 1.5mg · kapsula, tvrda · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)Same form
- Exelon®Serbia · 4.5mg · kapsula, tvrda · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)Same form
- Exelon®Serbia · 6mg · kapsula, tvrda · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)Same form
- EXELON 1.5 mg capsuleSaudi Arabia · Siegfried Barbera, S.LSame form
- EXELON 3 mg capsuleSaudi Arabia · Siegfried Barbera, S.LSame form
- EXELON 4.5 mg capsuleSaudi Arabia · Siegfried Barbera, S.LSame form
- EXELON CAPSULE 1.5 mgSingapore · 1.5 mg · capsule · Novartis (Singapore) Pte LTDSame form
- EXELON CAPSULE 3 mgSingapore · 3 mg · capsule · Novartis (Singapore) Pte LTDSame form
- EXELON CAPSULE 4.5 mgSingapore · 4.5 mg · capsule · Novartis (Singapore) Pte LTDSame form
- Rivastigmine TartrateUnited States · 1.5MG BASE, 3MG BASE, 4.5MG BASE … · capsule · Aurobindo PharmaSame form
- ExelonUnited States · 1.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 4.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** … · capsule · NovartisSame form
- rivastigminaBrazil · Aché Laboratórios Farmacêuticos S.ASame substance
- rivastigminaBrazil · Adium S.A.Same substance
- RivazichBrazil · Adium S.A.Same substance
- ExelonEuropean Union · Novartis Europharm LimitedSame substance
- NimvastidEuropean Union · Krka, d.d., Novo mestoSame substance
- PrometaxEuropean Union · Almirall, S.A.Same substance
- ExelonCroatiaSame substance
- NimvastidCroatiaSame substance
- PrometaxCroatiaSame substance
- Rivastigmine Patch BNM 10New Zealand · Patch 9.5 mg per 24 hourSame substance
- Rivastigmine Patch BNM 5New Zealand · Patch 4.6 mg per 24 hourSame substance
- ExelonUnited States · 13.3MG/24HR, 4.6MG/24HR, 9.5MG/24HR · film, extended release · SandozSame substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Rivastigmine
- Strength
- 1.5 MG
- Dosage form
- Capsule
- Route
- Oral
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 10 Feb 2020
- Registration
- DIN 02485362
- Marketing authorisation holder
- Jamp Pharma Corporation
- ATC code
- N06DA03
- Group
- Nervous system
- Supply
- PRESCRIPTION